Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10788092 | 0.90 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL11757771 | 0.82 | — | — | |
| SCHEMBL385017 | 0.78 | — | — | |
| SCHEMBL29473930 | 0.77 | — | — | |
| SCHEMBL5163671 | 0.77 | — | — | |
| SCHEMBL27859462 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| Water SCHEMBL7548465 | 0.74 | — | — | |
| SCHEMBL27494246 | 0.74 | TSHR (0.33) | TSHR | |
| SCHEMBL11765200 | 0.74 | — | — | |
| SCHEMBL11989343 | 0.74 | ALDH1A1 (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1249446-B1 | Use of thio derivates as flavoring ingredients | FIRMENICH & CIE (CH) | 2007-03-07 | — | — | EP | claimed |
| US-20030040460-A1 | Use of thio derivatives as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2003-02-27 | — | — | US | claimed |
| EP-1249446-A2 | Use of thio derivates as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2002-10-16 | — | — | EP | claimed |
| EP-4416125-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| EP-4225261-A1 | ANTIPERSPIRANT COMPOSITION | Coty Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023111006-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-06-22 | — | — | WO | disclosed |
| WO-2022076469-A1 | ANTIPERSPIRANT COMPOSITION | COTY INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3897957-A1 | PROCESS FOR PREPARING POLYAMIDE MICROCAPSULES | Firmenich SA (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3897956-A1 | POLYAMIDE MICROCAPSULES | Firmenich SA (CH) | 2021-10-27 | — | — | EP | disclosed |
| EP-3894064-A1 | PROCESS FOR PREPARING MICROCAPSULES | Firmenich SA (CH) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020234262-A1 | PROCESS FOR PREPARING MICROCAPSULES | FIRMENICH SA (CH) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020127749-A1 | PROCESS FOR PREPARING POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020127743-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2020-06-25 | — | — | WO | disclosed |
| EP-1249446-B1 | Use of thio derivates as flavoring ingredients | FIRMENICH & CIE (CH) | 2007-03-07 | — | — | EP | disclosed |
| US-7008919-B2 | Use of thio derivatives as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2006-03-07 | — | — | US | disclosed |
| US-20030040460-A1 | Use of thio derivatives as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2003-02-27 | — | — | US | disclosed |
| EP-1249446-A2 | Use of thio derivates as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 2002-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040460-A1 | Use of thio derivatives as perfuming and flavoring ingredients | TAS2R1, TAS2R4, TAS1R1 | ALDH1A1 166/4885TSHR 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.